FDA Inspection 1181546 — Blood Assurance Inc.
The FDA completed an inspection of Blood Assurance Inc. on October 13, 2022 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Nashville, TN (United States)